An international team of researchers led by Hokkaido University has characterized the unique mechanics that enable Arcella, a ...

Kyushu University scientists have achieved a major leap in fuel cell technology by enabling efficient proton transport at just 300°C. Their scandium-doped oxide materials create a wide, soft pathway ...

South African mobile-network operator Cell C Holdings Ltd. opened flat in its debut on the Johannesburg Stock Exchange, with the continent’s top bourse on track for its best year for funds raised from ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...

Korean biotechnology company, Nature Cell, is planning to open a stem cell facility in Baltimore, bringing 500 new jobs, the governor announced Tuesday. The 100,000 square foot manufacturing facility ...

In a new report from Bloomberg, it was said that studio Ubisoft San Francisco was working on a brand-new Splinter Cell title in 2017. After working on the project for months, those in charge at ...

A new cell phone waiting lot has opened at John Glenn Columbus International Airport, located closer to the terminal. The new lot provides an additional free option for drivers waiting to pick up ...

Derek's love of games came at an early age when his parents first brought home the Nintendo Entertainment System. From then on, countless nights were spent hunting ducks, stomping turtles, exploring ...

Hyundai is launching a slate of new vehicles, ranging from EVs to plug-in hybrids (PHEVs) and even fuel-cell electric vehicles. First launched in 2018, the Nexo marked a milestone as Hyundai’s first ...

Amazon chief executive Andy Jassy’s explanation for why the company is cutting 14,000 employees? Not money. Not even AI, but “culture.” The layoff announcement this week was “not really financially ...

People who received an infusion of stem cells shortly after a heart attack were less likely to develop heart failure than those treated with standard care, according to the largest such trial to date.

For years, cell and gene therapies were mainly associated with rare and orphan diseases, those that impact small patient groups and lack effective treatment options. However, recent developments in ...